¼¼°èÀÇ ¾È°ú Áø´Ü ½ÃÀå
Ophthalmology Diagnostics
»óǰÄÚµå : 1795977
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 392 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,245,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,736,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾È°ú Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 102¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 83¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾È°ú Áø´Ü ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 3.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 102¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °¢¸· ÅäÆ÷±×·¡ÆÛ´Â CAGR 3.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾ÈÀú Ä«¸Þ¶ó ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 23¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾È°ú Áø´Ü ½ÃÀåÀº 2024³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 6.6%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 20¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.5%¿Í 2.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾È°ú Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Áø´Ü Çõ½ÅÀÌ ¾ÆÀÌÄɾîÀÇ ¹Ì·¡¿¡ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¾È°ú¿ë Áø´ÜÀº ³ì³»Àå, ¹é³»Àå, ³ëÀμº Ȳ¹Ýº¯¼º(AMD), ´ç´¢¸Á¸·º´Áõ, ±¼Àý ÀÌ»óÀ» Æ÷ÇÔÇÑ ¾È°ú ÁúȯÀ» °¨Áö, ¸ð´ÏÅ͸µ, °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ µµ±¸¿Í ±â¼úÀ» Æ÷°ýÇÕ´Ï´Ù. ½Ã·ÂÀ» À§ÇùÇÏ´Â ´ëºÎºÐÀÇ ÁúȯÀº Ãʱ⿡´Â ¹«Áõ»óÀ̸ç, ÁøÇàµÇ¸é ȸº¹ÀÌ ºÒ°¡´ÉÇϱ⠶§¹®¿¡ ¾È°ú¿¡¼­´Â Áø´ÜÀÇ Á¤È®¼º°ú Á¶±â ¹ß°ßÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­, ´ç´¢º´, µðÁöÅÐ ´«ÀÇ ÇÇ·Î, ȯ°æÀû ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ½Ã·Â Àå¾Ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áø´ÜÀÇ ¿ªÇÒÀº Áö¿ø ±â´É¿¡¼­ ¿¹¹æÀûÀ̰í Á¤¹ÐÇÑ ¾È°ú ÀǷḦ ½ÇÇöÇÏ´Â ÃÖÀü¹æÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä Áø´Ü ¹æ¹ýÀ¸·Î´Â ºû°£¼·´ÜÃþÃÔ¿µ(OCT), ¾ÈÀú»çÁø, ½Ã¾ß ºÐ¼®, ¾È¾Ð ÃøÁ¤, °¢¸· ÅäÆ÷±×·¡ÇÇ, Ç÷ç¿À·¹¼¼ÀÎ Ç÷°üÁ¶¿µ¼ú, ¾È±¸ »ýü ÃøÁ¤ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº AI ±â¹Ý ¿µ»ó ºÐ¼®, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ °øÀ¯, ¸ÖƼ¸ð´Þ ¿µ»ó ÅëÇÕÀ» ÅëÇØ ´õ¿í Æ÷°ýÀûÀÌ°í ½Ç½Ã°£ÀûÀÎ ÀÓ»óÀû ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ Á¡Á¡ ´õ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¾È°ú ÀÇ·á ¼­ºñ½º´Â ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, Áø´Ü Ç÷§ÆûÀº ÇöÀç ÀÏ¹Ý ¾È°ú, ¸Á¸·, ³ì³»Àå, ¼Ò¾Æ°ú, ±¼Àý±³Á¤ µî °¢ ¼¼ºÎ Àü¹® ºÐ¾ßÀÇ ÀÇ»ç°áÁ¤À» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Áø´ÜÀÇ ¼Óµµ, ±íÀÌ, Á¢±Ù¼ºÀ» ³ôÀÌ´Â ½Å±â¼úÀ̶õ?

¾È°ú¿ë Áø´Ü±â±âÀÇ ÁøÈ­´Â ºñħ½ÀÀû, °íÇØ»óµµ, µðÁöÅÐ ÅëÇÕ ½Ã½ºÅÛÀ¸·ÎÀÇ ÀüȯÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ±¤°£¼·´ÜÃþÃÔ¿µ±â(OCT)´Â ¸Á¸·°ú ½Ã½Å°æ ±¸Á¶ÀÇ ¸¶ÀÌÅ©·Î¹ÌÅÍ ÇØ»óµµÀÇ ´Ü¸é ¿µ»óÀ» Á¦°øÇϸç, ±× ÇÙ½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ºÀ¬±¤¿ø OCT, OCT¾Þ±â¿À±×·¡ÇÇ(OCTA), ÀûÀÀ±¤ÇÐ µîÀÇ ±â¼ú Çõ½ÅÀ¸·Î Á¶¿µÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°íµµ ´õ ±íÀº Á¶Á÷ ħÅõ, °í¼Ó ½ºÄµ, Ç÷·ù ºÐ¼®ÀÌ °¡´ÉÇØÁ® ´ç´¢È²¹ÝºÎÁ¾, Ç÷°ü½Å»ý AMD, ³ì³»Àå Áø´Ü¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

ÀΰøÁö´ÉÀº ÇØ¼®À» ÀÚµ¿È­Çϰí Áø´ÜÀÇ ÆíÂ÷¸¦ ÁÙÀ̱â À§ÇØ Áø´Ü Ç÷§Æû¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. AI°¡ žÀçµÈ ¸Á¸· ¿µ»ó ±×·¹À̵ù ½Ã½ºÅÛÀº ¾ÈÀú »çÁøÀ̳ª OCT ½ºÄµ¿¡¼­ Ãßõ °¡´ÉÇÑ ´ç´¢¸Á¸·º´Áõ, ³ì³»Àå ÀǽÉ, AMD¸¦ ¼÷·ÃµÈ ÀÓ»óÀÇ¿¡ ÇÊÀûÇÏ´Â ¹Î°¨µµ¿Í ƯÀ̵µ·Î °ËÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº ½ºÅ©¸®´× ÇÁ·Î±×·¥, ÀÏÂ÷ Áø·á, ¿ø°Ý ¾È°ú ³×Æ®¿öÅ©¿¡¼­ »ç¿ëµÇ¾î Á¶±â Áø´ÜÀ» °³¼±Çϰí Àü¹®ÀÇ ÀÇ·Ú¸¦ °£¼ÒÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

ÈÞ´ë¿ë ¹× ½º¸¶Æ®Æù ±â¹Ý Áø´Ü Àåºñ´Â ƯÈ÷ ÀúÀÚ¿ø ȯ°æ¿¡¼­ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ½º¸¶Æ®Æù ¾ÈÀú Ä«¸Þ¶ó, ÈÞ´ë¿ë ½½¸´ ·¥ÇÁ, ¾Û ±â¹Ý ½Ã·Â °Ë»ç µîÀÇ µµ±¸¸¦ ÅëÇØ ÇöÀå ÀÛ¾÷ÀÚ°¡ ¿ø°Ý ºÐ¼®À» À§ÇØ µ¥ÀÌÅ͸¦ ¼öÁýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüÀÚÀǹ«±â·Ï(EMR) ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼ºÀ» ÅëÇØ ¾È°ú ¹× Àü½Å Ä¡·á °æ·Î¿¡ °ÉÃÄ È¯ÀÚ¸¦ Àå±âÀûÀ¸·Î ÃßÀûÇϰí ÀÇ»ç°áÁ¤À» °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¾î¶² ÀÓ»ó »ç¿ë »ç·Ê¿Í ¼¼°è Æ®·»µå°¡ ½ÃÀå µµÀÔÀ» È®´ëÇϰí Àִ°¡?

Áø´Ü µµ±¸´Â ÀÏÂ÷ °ËÁø ¹× º´±â ºÐ·ù¿¡¼­ ¼ö¼ú °èȹ ¹× ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µ¿¡ À̸£±â±îÁö »ç½Ç»ó ¸ðµç ¾È°ú ¿öÅ©Ç÷οìÀÇ Áß½ÉÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ³ì³»Àå Ä¡·á¿¡¼­´Â ¾È¾Ð ÃøÁ¤, ÁÖº¯ºÎ ÃøÁ¤, ¸Á¸· ½Å°æ¼¶À¯Ãþ OCT°¡ Áø´Ü°ú ÁøÇà ÃßÀûÀ» À§ÇÑ Ç¥ÁØÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸Á¸· Àü¹®ÀÇ´Â Ç÷°ü¼º, ¿°Áõ¼º, ÅðÇ༺ ÁúȯÀÇ °¨º°À» À§ÇØ Ç÷ç¿À·¹¼¼ÀÎ Ç÷°üÁ¶¿µ¼ú, OCT, ¾ÈÀú ÀÚ¹ßÀû Çü±¤À» °áÇÕÇÑ ¸ÖƼ¸ð´Þ ¿µ»ó Áø´Ü¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

±¼Àý±³Á¤ ¹× ¹é³»Àå Àü¹®ÀÇ´Â °¢¸· ÁöÇüµµ, ÆÄ¸é ¼öÂ÷°è, ±¤ÇÐ »ýüÀÎ½Ä ±â¼úÀ» »ç¿ëÇÏ¿© ¸ÂÃãÇü ·»Áî À̽ÄÀ» °èȹÇϰí ÃÖÀûÀÇ ½Ã·Â °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ÈÞ´ë¿ë ÀÚµ¿±¼Àý°Ë»ç±â, ½Ã·Â°Ë»çÇ¥, ¾ç¾È½Ã·Â°Ë»ç µî ¼Ò¾Æ Áø´Ü±â±â´Â ¾à½Ã³ª ±¼ÀýÀÌ»óÀÇ Á¶±â ¹ß°ßÀÌ Çо÷ ¹× ¹ß´Þ ¼º°ú¿Í Á÷°áµÇ±â ¶§¹®¿¡ ±× Á߿伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é ¾È°ú Áø´Ü ¾àǰ¿¡ ´ëÇÑ ¼ö¿ä´Â ¼º¼÷ ½ÃÀå°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡¼­ °­¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ºÏ¹Ì¿Í À¯·´¿¡¼­´Â Á¾ÇÕÀûÀÎ Àü¹® ÀǷḦ À§ÇØ AI Áö¿ø Áø´Ü Ç÷§Æû°ú ÅëÇÕ ¿µ»ó ó¸® Á¦Ç°±º¿¡ ´ëÇÑ ÅõÀÚ°¡ °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, ¾ÆÇÁ¸®Ä« ÀϺΠÁö¿ª¿¡¼­´Â ±¹°¡ ½Ç¸í ¿¹¹æ ÇÁ·Î±×·¥ ¹× ³óÃÌ Áö¿ª Áö¿ø Ȱµ¿À» Áö¿øÇϱâ À§ÇØ Àú·ÅÇÑ °¡°ÝÀÇ ÈÞ´ë¿ë Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå È®´ë¿Í ¹Ì·¡ Çõ½ÅÀ» À̲ô´Â ÈûÀº ¹«¾ùÀϱî?

¼¼°è ¾È°ú Áø´Ü ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ½Ã·Â °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ¸¸¼ºÁúȯÀÇ È®»ê, Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀÔ´Ï´Ù. ÇöÀç Ãß¼¼´ë·Î¶ó¸é 2050³â±îÁö Àü ¼¼°è ½Ç¸íÀÚ ¼ö°¡ 1¾ï 1,500¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ±â ¶§¹®¿¡ ÀÇ·á ½Ã½ºÅÛÀº Á¶±â Áø´Ü ¹× °ËÁø ÀÎÇÁ¶ó¸¦ Á¡Á¡ ´õ ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. ½Ã°¢Àå¾Ö·Î ÀÎÇÑ »çȸ°æÁ¦Àû ºÎ´ãÀ» ÇÇÇϱâ À§Çؼ­´Â Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸°¡ ÇʼöÀûÀÔ´Ï´Ù.

ºñÀü 2020, WHOÀÇ º¸ÆíÀû ¾Èº¸°Ç ÀÌ´Ï¼ÅÆ¼ºê, Àü±¹ÀûÀÎ °ËÁø Ä·ÆäÀΰú °°Àº Á¤ºÎ ÇÁ·Î±×·¥Àº Áø´Ü ¿ª·®À» È®´ëÇϱâ À§ÇØ ÀÚ±ÝÀ» ÇÒ´çÇϰí ÀÖ½À´Ï´Ù. Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ º¸Çè Àû¿ë°ú °¡Ä¡¿¡ ±â¹ÝÇÑ Ä¡·á ¸ðµ¨ÀÇ ºÎ»óÀ¸·Î ÀÎÇØ Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. µ¿½Ã¿¡ ±â±â Á¦Á¶¾÷ü, AI ½ºÅ¸Æ®¾÷, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ Á¦Ç° Çõ½Å°ú ½ÃÀå ħÅõ°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

Topcon, Zeiss, Haag-Streit, Nidek, Heidelberg Engineering, Optovue µîÀÇ ±â¾÷µéÀº Àü¹®ÀÇ¿Í ÀϹÝÀÇ»çÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ AI ÅëÇÕ, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º, Å©·Î½º Ç÷§Æû ȣȯ¼º¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÇâÈÄ °³¹ßµÉ Á¦Ç°¿¡´Â ¿µ»ó Áø´Ü, »ýÃ¼ÃøÁ¤, ±â´É°Ë»ç¸¦ Çϳª·Î ÅëÇÕÇÑ ÇÏÀ̺긮µå ±â±â³ª ¸Ó½Å·¯´×À» ÅëÇØ Áø´Ü ¼º´ÉÀ» Áö¼ÓÀûÀ¸·Î Çâ»ó½ÃŰ´Â Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼® ¿£ÁøÀÌ Æ÷Ç﵃ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

°íÇ÷¾Ð, ³úÁ¹Áß, ¾ËÃ÷ÇÏÀ̸ÓÀÇ ¸Á¸·Áõ»ó µî Àü½ÅÁúȯ ¸ð´ÏÅ͸µ¿¡¼­ ¾È±¸ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Á߿伺ÀÌ Ä¿Áö¸é¼­ ¾È°ú Áø´ÜÀº ÅëÇÕÀÇ·á Á¦°ø¿¡ ÀÖ¾î ´õ Å« ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù. µðÁöÅÐ Çコ, AI, ¿ø°ÝÀÇ·áÀÇ À¶ÇÕÀ¸·Î Àü ¼¼°èÀûÀ¸·Î Áø´ÜÀÌ ¹ß°ß µµ±¸¿¡¼­ ¿¹¹æÀûÀ̰í Á¤¹ÐÇÑ ½Ã·Â °ü¸®ÀÇ Ãʼ®ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(°¢¸· ÅäÆ÷±×·¡ÆÛ, ¾ÈÀú Ä«¸Þ¶ó, °Ë¾È°æ, OCT ½ºÄ³³Ê, ¸Á¸·°æ, ±¼Àý°è, ±âŸ ¾È°ú Áø´Ü), ¿ëµµ(¸Á¸· Æò°¡ ¿ëµµ, ³ì³»Àå °ËÃâ ¿ëµµ, ¼ö¼ú Æò°¡ ¿ëµµ, ±¼Àý Æò°¡ ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Àü¹® Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ophthalmology Diagnostics Market to Reach US$10.2 Billion by 2030

The global market for Ophthalmology Diagnostics estimated at US$8.3 Billion in the year 2024, is expected to reach US$10.2 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Corneal Topographers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Fundus Cameras segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Ophthalmology Diagnostics market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Ophthalmology Diagnostics Market - Key Trends & Drivers Summarized

Why Is Diagnostic Innovation Central to the Future of Eye Care?

Ophthalmology diagnostics encompass a broad range of tools and technologies used to detect, monitor, and manage ocular diseases including glaucoma, cataracts, age-related macular degeneration (AMD), diabetic retinopathy, and refractive errors. Diagnostic accuracy and early detection are paramount in ophthalmology, as many vision-threatening conditions are asymptomatic in early stages and irreversible once advanced. The rise in global vision impairment, driven by aging populations, diabetes, digital eye strain, and environmental factors, is elevating the role of diagnostics from a support function to a frontline enabler of preventive and precision eye care.

Core diagnostic modalities include optical coherence tomography (OCT), fundus photography, visual field analysis, tonometry, corneal topography, fluorescein angiography, and ocular biometry. These technologies are increasingly being augmented by AI-powered image analysis, cloud-based data sharing, and multi-modal imaging integration to enable more comprehensive and real-time clinical insights. Eye care delivery is evolving rapidly, and diagnostic platforms now underpin decision-making across general ophthalmology, retina, glaucoma, pediatric, and refractive subspecialties.

How Are Emerging Technologies Enhancing Diagnostic Speed, Depth, and Accessibility?

The evolution of ophthalmology diagnostics is marked by a shift toward non-invasive, high-resolution, and digitally integrated systems. Optical coherence tomography (OCT) continues to be a cornerstone, offering micrometer-resolution cross-sectional imaging of retinal and optic nerve structures. Innovations like swept-source OCT, OCT angiography (OCTA), and adaptive optics are enabling deeper tissue penetration, faster scanning, and blood flow analysis without contrast dyes-transforming the diagnosis of diabetic macular edema, neovascular AMD, and glaucoma.

Artificial intelligence is being integrated into diagnostic platforms to automate interpretation and reduce diagnostic variability. AI-powered retinal image grading systems can detect referable diabetic retinopathy, glaucoma suspects, and AMD from fundus photographs and OCT scans with sensitivity and specificity rivaling that of experienced clinicians. These solutions are being used in screening programs, primary care settings, and teleophthalmology networks to improve early diagnosis and streamline specialist referrals.

Portable and smartphone-based diagnostic devices are enhancing accessibility, especially in low-resource settings. Tools like smartphone fundus cameras, hand-held slit lamps, and app-based visual acuity tests allow frontline workers to capture data for remote analysis. Moreover, interoperability with electronic medical records (EMR) systems is enabling longitudinal patient tracking and shared decision-making across ophthalmic and systemic care pathways.

Which Clinical Use Cases and Global Trends Are Expanding Market Uptake?

Diagnostic tools are central to virtually every ophthalmic workflow, from primary screening and disease staging to surgical planning and postoperative monitoring. In glaucoma care, for example, intraocular pressure measurement, perimetry, and OCT of the retinal nerve fiber layer are standard for diagnosis and progression tracking. Retinal specialists rely on multimodal imaging-combining fluorescein angiography, OCT, and fundus autofluorescence-to differentiate between vascular, inflammatory, and degenerative conditions.

Refractive and cataract surgeons use corneal topography, wavefront aberrometry, and optical biometry to plan customized lens implants and ensure optimal visual outcomes. Pediatric diagnostics-including handheld autorefractors, vision screening charts, and binocular vision tests-are gaining importance as early detection of amblyopia and refractive errors has been linked to better academic and developmental outcomes.

Regionally, the demand for ophthalmology diagnostics is strong across both mature and emerging markets. North America and Europe continue to invest in AI-enabled diagnostic platforms and integrated imaging suites for comprehensive specialty care. Meanwhile, Asia-Pacific, Latin America, and parts of Africa are experiencing a surge in demand for low-cost, portable diagnostic solutions to support national blindness prevention programs and rural outreach.

What Forces Are Driving Market Expansion and Future Innovation?

The growth in the global ophthalmology diagnostics market is driven by rising vision care needs, expanding geriatric populations, growing chronic disease prevalence, and continuous technological advancements. With global blindness expected to reach 115 million by 2050 if current trends persist, healthcare systems are increasingly prioritizing early diagnosis and screening infrastructure. Diagnostic tools that enable timely intervention are critical to avoid the socio-economic burden of visual disability.

Government programs such as Vision 2020, the WHO’s Universal Eye Health initiative, and national screening campaigns are allocating funds to scale diagnostic capabilities. Insurance coverage for diagnostic procedures and the rise of value-based care models are improving affordability and utilization. Simultaneously, strategic partnerships between device manufacturers, AI startups, and healthcare providers are accelerating product innovation and market penetration.

Companies such as Topcon, Zeiss, Haag-Streit, Nidek, Heidelberg Engineering, and Optovue are investing in AI integration, user-friendly interfaces, and cross-platform compatibility to meet the needs of both specialists and generalists. Future developments are likely to include hybrid devices that combine imaging, biometry, and functional tests in a single unit, as well as cloud-based analytics engines that continuously improve diagnostic performance through machine learning.

With the growing importance of ocular biomarkers in systemic disease monitoring-such as retinal signs of hypertension, stroke, or Alzheimer’s-ophthalmology diagnostics are positioned to play a larger role in integrated healthcare delivery. The convergence of digital health, AI, and telemedicine will continue to elevate diagnostics from a tool of detection to a cornerstone of preventive and precision vision care worldwide.

SCOPE OF STUDY:

The report analyzes the Ophthalmology Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Corneal Topographers, Fundus Cameras, Ophthalmoscopes, OCT Scanners, Retinoscopes, Refractors, Other Ophthalmology Diagnostics); Application (Retinal Evaluation Application, Glaucoma Detection Application, Surgical Evaluation Application, Refraction Assessment Application, Other Applications); End-User (Hospitals End-User, Specialty Clinics End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â